Open Market Insiders Trades - Sells only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
RDFN
|
Christopher John Nielsen
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 12.73% |
$234,060
$78.02 p/Share
|
Jan 19
2021 |
|
ALEC
|
Robert Paul
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 12.31% |
$543,600
$18.12 p/Share
|
Jan 19
2021 |
|
MORF
|
Omega Fund V, L.P.
Director |
SELL
Open market or private sale
|
Direct | 17,238 Reduced 0.61% |
$517,657
$30.03 p/Share
|
Jan 19
2021 |
|
GNK
|
Ccp Ii Cayman Gp Ltd.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 18,864 Reduced 0.84% |
$166,192
$8.81 p/Share
|
Jan 19
2021 |
|
GNK
|
Ccp Ii Cayman Gp Ltd.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 21,136 Reduced 0.92% |
$186,208
$8.81 p/Share
|
Jan 19
2021 |
|
GNK
|
Centerbridge Credit Partners, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 18,864 Reduced 0.84% |
$166,192
$8.81 p/Share
|
Jan 19
2021 |
|
GNK
|
Centerbridge Credit Partners, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 21,136 Reduced 0.92% |
$186,208
$8.81 p/Share
|
Jan 19
2021 |
|
YMAB
|
Thomas Gad
CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Indirect | 4,000 Reduced 0.65% |
$186,240
$46.56 p/Share
|
Jan 19
2021 |
|
YMAB
|
Thomas Gad
CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct | 7,000 Reduced 100.0% |
$325,570
$46.51 p/Share
|
Jan 19
2021 |
|
QTRX
|
E Kevin Hrusovsky
Executive Chairman |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 0.49% |
$375,350
$75.07 p/Share
|
Jan 19
2021 |
|
BLFS
|
Walter Villiger
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 40,000 Reduced 1.15% |
$1,612,000
$40.3 p/Share
|
Jan 19
2021 |
|
CHRS
|
Vincent R Anicetti
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 2,500 Reduced 4.02% |
$44,850
$17.94 p/Share
|
Jan 19
2021 |
|
NTGR
|
Andrew Wonki Kim
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 781 Reduced 1.04% |
$30,123
$38.57 p/Share
|
Jan 19
2021 |
|
RMNI
|
David W. Rowe
CPO,CMO&EVPGlob.Transformation |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 7.9% |
$105,000
$7.0 p/Share
|
Jan 19
2021 |
|
RMNI
|
Kevin Maddock
EVP,ChiefRecurringRev.Officer |
SELL
Open market or private sale
|
Direct | 5,320 Reduced 7.16% |
$37,293
$7.01 p/Share
|
Jan 19
2021 |
|
SFIX
|
Katrina Lake
Director |
SELL
Open market or private sale
|
Indirect | 43,774 Reduced 49.72% |
$3,320,696
$75.86 p/Share
|
Jan 19
2021 |
|
BCYC
|
Kevin Lee
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 1.89% |
$150,750
$30.15 p/Share
|
Jan 19
2021 |
|
BCYC
|
Lee Kalowski
President and CFO |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 100.0% |
$450,000
$30.0 p/Share
|
Jan 19
2021 |
|
SIBN
|
Anthony J Recupero
President, Commercial Ops |
SELL
Open market or private sale
|
Direct | 2,653 Reduced 2.25% |
$76,964
$29.01 p/Share
|
Jan 19
2021 |
|
SIBN
|
Jeffrey W Dunn |
SELL
Open market or private sale
|
Direct | 3,268 Reduced 0.95% |
$94,805
$29.01 p/Share
|
Jan 19
2021 |
|
SIBN
|
Michael A Pisetsky
SVP, Ops & Adm/Chief Legal Ofr |
SELL
Open market or private sale
|
Direct | 910 Reduced 1.18% |
$26,399
$29.01 p/Share
|
Jan 19
2021 |
|
MITK
|
Michael E Diamond |
SELL
Open market or private sale
|
Direct | 43,373 Reduced 19.97% |
$730,401
$16.84 p/Share
|
Jan 19
2021 |
|
SGH
|
Alan Marten
Senior Vice President |
SELL
Open market or private sale
|
Direct | 2,800 Reduced 2.36% |
$112,000
$40.0 p/Share
|
Jan 19
2021 |
|
BTAI
|
Vincent O'Neill |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 100.0% |
$1,260,000
$50.4 p/Share
|
Jan 19
2021 |
|
QUOT
|
Steven R. Boal
Director |
SELL
Open market or private sale
|
Direct | 41,502 Reduced 1.16% |
$415,435
$10.01 p/Share
|
Jan 19
2021 |
|
OMER
|
Michael A Jacobsen
VP, Finance & CAO |
SELL
Open market or private sale
|
Direct | 9,500 Reduced 70.37% |
$189,525
$19.95 p/Share
|
Jan 19
2021 |
|
EVER
|
Jayme Mendal
CEO and President |
SELL
Open market or private sale
|
Direct | 166 Reduced 0.08% |
$6,645
$40.03 p/Share
|
Jan 19
2021 |
|
LQDA
|
Eshelman Ventures, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 93,835 Reduced 1.55% |
$278,690
$2.97 p/Share
|
Jan 19
2021 |
|
GTHX
|
Mark A. Velleca |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 21.28% |
$208,800
$20.88 p/Share
|
Jan 19
2021 |
|
SMLR
|
Douglas Murphy Chutorian
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 1,250 Reduced 0.38% |
$114,200
$91.36 p/Share
|
Jan 19
2021 |
|
GRTS
|
Raphael Rousseau
Officer |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 100.0% |
$350,600
$17.53 p/Share
|
Jan 19
2021 |
|
GRTS
|
Roman Yelensky
Officer |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 6.98% |
$221,000
$22.1 p/Share
|
Jan 19
2021 |
|
KVHI
|
Brent C Bruun
CEO |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 2.81% |
$50,000
$12.5 p/Share
|
Jan 19
2021 |
|
KVHI
|
Robert J Balog
COO |
SELL
Open market or private sale
|
Direct | 467 Reduced 0.53% |
$5,838
$12.5 p/Share
|
Jan 19
2021 |
|
KVHI
|
Van Heyningen Martin Kits |
SELL
Open market or private sale
|
Indirect | 68 Reduced 0.57% |
$850
$12.5 p/Share
|
Jan 19
2021 |
|
PTE
|
David B Seaburg
Director |
SELL
Open market or private sale
|
Direct | 31,037 Reduced 3.41% |
$33,830
$1.09 p/Share
|
Jan 19
2021 |
|
PED
|
Ivar Siem |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 29.41% |
$70,000
$1.4 p/Share
|
Jan 19
2021 |
|
XGN
|
Hunt Holdings Limited Partnership
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 30,000 Reduced 2.11% |
$480,000
$16.0 p/Share
|
Jan 19
2021 |
|
SURF
|
Jeff Goater
Director |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 1.87% |
$65,000
$13.0 p/Share
|
Jan 19
2021 |
|
TRHC
|
Orsula V Knowlton
CO-PRESIDENT |
SELL
Open market or private sale
|
Direct | 8,000 Reduced 1.13% |
$419,520
$52.44 p/Share
|
Jan 19
2021 |
|
TRHC
|
Calvin H Knowlton
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect | 8,000 Reduced 0.57% |
$419,520
$52.44 p/Share
|
Jan 19
2021 |
|
BCEL
|
Norman Michael Greenberg
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 100.0% |
$76,050
$15.21 p/Share
|
Jan 19
2021 |
|
SALM
|
David Evans
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 2,400 Reduced 31.99% |
$3,960
$1.65 p/Share
|
Jan 19
2021 |
|
MTBC
|
A Hadi Chaudhry
CEO |
SELL
Open market or private sale
|
Direct | 4,334 Reduced 5.57% |
$45,550
$10.51 p/Share
|
Jan 19
2021 |
|
TYME
|
Michael Demurjian
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 0.08% |
$39,000
$1.95 p/Share
|
Jan 19
2021 |
|
APLT
|
Riccardo Perfetti
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 465 Reduced 100.0% |
$10,151
$21.83 p/Share
|
Jan 19
2021 |
|
OPXS
|
Ephraim G Fields
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 9,299 Reduced 0.79% |
$19,342
$2.08 p/Share
|
Jan 19
2021 |
|
LOVE
|
Shawn David Nelson
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 6,000 Reduced 4.87% |
$297,000
$49.5 p/Share
|
Jan 19
2021 |
|
MDLA
|
Elizabeth Carducci
EVP & Chief Revenue Officer |
SELL
Open market or private sale
|
Direct | 60,000 Reduced 7.56% |
$2,354,400
$39.24 p/Share
|
Jan 19
2021 |
|
MDLA
|
Borge Hald
Director |
SELL
Open market or private sale
|
Direct | 79,041 Reduced 3.53% |
$3,164,011
$40.03 p/Share
|
Jan 19
2021 |